De Committee for Medicinal Products for Human Use (CHMP) heeft een positief advies gegeven over nieuwe handelsvergunningen voor drie geneesmiddelen: turoctocog alfa pegol (Esperoct), hydroxycarbamide (Xromi) en...
Latest articles
FDA authorizes marketing of first medical device for pain relief in adolescents with IBS
The U.S. Food and Drug Administration today permitted marketing of the first medical device to aid in the reduction of functional abdominal pain in patients 11-18 years of age with irritable bowel syndrome when combined...
Healthcare solutions of the future: Boehringer Ingelheim relies on digitalization
Digitalization is changing the healthcare system: Digital technologies are opening up new opportunities in the development of innovative medications and the healthcare solutions of tomorrow.
AstraZeneca’s Phase 3 Farxiga data impresses in type 2 diabetes
AstraZeneca has presented new Phase 3 data at the American Diabetes Association (ADA) 79th Scientific Sessions in San Francisco on its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin)...
Het belang van personalisatie in digital marketing
Een soort heilige graal waar je niet altijd volledig grip op kunt krijgen als marketeer. Terwijl we dat zo graag willen. Bijna twee derde van de digital marketeers (pdf) vindt personalisatie het moeilijkste onderdeel...
MSD scoops up biopharma firm Tilos for $773 million
US-based firm MSD has announced its intends to acquire biopharma firm Tilos Therapeutics, and has signed a deal with the company to this effect, valued to a total of $773 million. This new deal means that MSD will...
